Also known as آسٹیوپوروسس مینجمنٹ
General Physician
M.B.B.S., MRCGP (UK)
Internal Medicine Specialist
MBBS, MCPS Family Medicine
Internal Medicine Specialist
MBBS, MCPS (Family Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Consultant Physician
MBBS, FCPS (Medicine), FCPS Endo (Fellow), MRCP (Glasgow), MRCP-SCE UK Endo Diabetes , MGEAD (UAE), Dip Diabetes (UK)
Consultant Physician
MBBS, FCPS (Medicine), FCPS Endo (Fellow), MRCP (Glasgow), MRCP-SCE UK Endo Diabetes , MGEAD (UAE), Dip Diabetes (UK)
Internal Medicine Specialist
MBBS, MCPS (Family Medicine)
Nephrologist
MBBS, Diplomate American Board Nephrology
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Gastroenterologist
MBBS, FCPS (Gastroenterology), European Speciality Certificate in Gastroenterology and Hepatalogy (UK)
Gastroenterologist
MBBS, FCPS (Gastroenterology), European Speciality Certificate in Gastroenterology and Hepatalogy (UK)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures